Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
national blog main
boston blog main
boston top stories
crispr
editas medicine
gene editing
katrine bosley
national
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
allergan
andrew oxtoby
artificial intelligence
babies
boston
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
ceo
clinical hold
clinical study
clinical trials
combination
commissioner
congress
crispr-cas9
cynthia collins
delisting
democrats
departure
detroit blog main
detroit top stories
drug pricing
drugs
eli lilly
What
ceo
3
×
medicine
crispr
editas
katrine
alex
allergan
announced
big
bio
blessing
bosley
bosley's
bosley’s
bridge
bucks
cas
check
clinical
collaboration
crime
cusp
depart
departure
discovery
drug
editing
entered
exit
experimental
gene
guiding
humans
insilico
million
moves
partner
personnel
pfizer
regulatory
Language
unset
Current search:
medicine���s
×
biotech
×
ceo
×
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial